Introducing Sertraline Hydrochloride Tablets by PharmAlliance International Labs Private Limited

Welcome to PharmAlliance International Labs, a beacon of excellence in the pharmaceutical industry dedicated to fostering health and wellness worldwide. Our Sertraline Hydrochloride Tablets represent a cornerstone in the treatment of various mental health disorders, underpinned by our unwavering commitment to quality, innovation, and patient-centric care.

Drug Class:

Sertraline Hydrochloride belongs to the class of medications known as selective serotonin reuptake inhibitors (SSRIs). Renowned for their efficacy in treating major depressive disorder (MDD), anxiety disorders, obsessive-compulsive disorder (OCD), panic disorder, and post-traumatic stress disorder (PTSD), SSRIs function by selectively increasing serotonin levels in the brain, thereby mitigating symptoms associated with mood and anxiety disorders.

Formulations:

Our Sertraline Hydrochloride Tablets are meticulously formulated to provide optimal therapeutic effects and patient convenience. Available in two strengths, 50mg tablets (packed in 30’s) and 100mg tablets (packed in 20’s), each tablet is designed for oral administration and packaged for easy dosing.

Indications:

Sertraline Hydrochloride Tablets are indicated for the treatment of:

• Major Depressive Disorder (MDD)
• Obsessive-Compulsive Disorder (OCD)
• Panic Disorder
• Social Anxiety Disorder
• Post-Traumatic Stress Disorder (PTSD)

Usage and Dosage:

To maximize the therapeutic benefits of Sertraline Hydrochloride Tablets, they should be taken orally, usually once daily, with or without food, as prescribed by your healthcare provider. Adherence to the prescribed dosage and treatment duration is crucial for achieving optimal outcomes. Abrupt discontinuation of sertraline should be avoided, and any changes in treatment should be discussed with your healthcare provider to mitigate potential withdrawal symptoms.

Dosage:

The recommended starting dose of sertraline for adults is typically 50 mg once daily, with adjustments made by the healthcare provider based on individual response and tolerability. Dosage may be gradually increased, up to a maximum of 200mg per day for certain conditions. Lower starting doses may be warranted for elderly patients or those with hepatic or renal impairment.

Pharmacokinetics:

Following oral administration, sertraline is readily absorbed, with peak plasma concentrations achieved within 4 to 8 hours. Metabolized primarily by the hepatic cytochrome P450 enzyme system, particularly CYP2C19 and CYP2B6, sertraline boasts an elimination half-life of approximately 24 to 36 hours, facilitating once-daily dosing and consistent therapeutic effects.

Pharmacodynamics:

As an SSRI, sertraline selectively inhibits the reuptake of serotonin (5-HT) at the synaptic cleft, thereby augmenting serotonin neurotransmission in the brain. By enhancing serotonin levels, sertraline alleviates symptoms of depression, anxiety, and other related disorders, thereby promoting improved mental well-being.

Side Effects:

Common side effects of Sertraline Hydrochloride Tablets may include nausea, diarrhea, insomnia, dizziness, dry mouth, and sexual dysfunction. Some individuals may experience weight changes, sweating, tremors, or headache. While rare, serious side effects such as serotonin syndrome, suicidal ideation, and hyponatremia may occur. Prompt reporting of any unusual symptoms or adverse reactions to your healthcare provider is essential.

Trust in PharmAlliance International Labs:

Place your trust in the efficacy and safety of Sertraline Hydrochloride Tablets from PharmAlliance International Labs. Committed to enhancing the lives of our patients, we prioritize quality, innovation, and patient well-being in all that we do. For further information, please visit our website or consult your healthcare provider. Your health is our priority.